Prednisolone and Cooling Responses in 13 Adults
Evidence note: the lifestyle scene is a fictional AI-assisted illustration. It does not depict a study participant, clinician endorsement, diagnosis, or before/after result.
Why this active-life question matters
Thirteen healthy adults completed a randomized double-blind crossover of one week of prednisolone and placebo. The practical value is not a promise that one routine or product works for everyone. It is a closer look at how a specific exposure was measured, which comparison was made, and how much uncertainty remains.
Busy adults move between climate-controlled rooms, protective equipment, repeated washing, exercise, footwear and bathing. Those settings can change surface water, temperature, occlusion and measurement conditions. A reading such as transepidermal water loss is useful only when the anatomical site, acclimation, environment and timing are kept in view.
Study snapshot
| Evidence element | What the paper reports |
|---|---|
| Population and design | Thirteen healthy adults completed a randomized double-blind crossover of one week of prednisolone and placebo. |
| Comparator | Prednisolone 15 mg/day versus placebo |
| Timepoint/exposure | After one week, during 19°C cooling and after a standardized meal |
| Numerical result | During cooling, supraclavicular temperature change was −1.0±0.1°C with prednisolone versus −0.45±0.1°C with placebo (P<0.01); BAT FDG uptake also fell. |
| Important limitation | Small drug-mechanism study; it is not a skincare trial and must not guide corticosteroid use without a prescriber. |
| Funding | No grant information was displayed in the PubMed record reviewed. |
| Conflicts | Not reported in the PubMed record. |
What the investigators actually did
AIM: To investigate the effect of glucocorticoids on brown adipose tissue (BAT) function in humans. MATERIALS AND METHODS: In a randomized double-blind cross-over design, 13 healthy adults underwent 1 week of oral prednisolone treatment (15 mg/d) and placebo with an intervening 2-week wash-out period. BAT function was assessed in response to cooling (19°C) and to a standardized meal, by measuring fluoro-deoxyglucose (FDG) uptake using positron emission tomography-computed tomography and skin temperatures overlying the supraclavicular (SCL) BAT depots using infrared thermography. Postprandial energy and substrate metabolism was assessed by indirect calorimetry. RESULTS: During cooling, prednisolone significantly reduced BAT FDG uptake (standardized uptake value, SUVmax, 6.1 ± 2.2 vs 3.7 ± 1.2; P < .05) and SCL temperature (-0.45 ± 0.1 vs -1.0 ± 0.1°C; P < .01) compared to placebo. Postprandially, prednisolone significantly blunted the rise in SCL temperature (+0.2 ± 0.1 vs -0.3 ± 0.1°C; P < .05), enhanced energy production (+221 ± 17 vs +283 ± 27 kcal/d; P < .01) and lipid synthesis (+16.3 ± 3.2 vs +23.6 ± 4.9 mg/min; P < .05). The prednisolone-induced reduction in SCL temperature significantly correlated with the reduction in FDG uptake (r = 0.65, P < .05), while the increase in energy production significantly correlated with the increase in lipogenesis (r = 0.6, P < .05). CONCLUSION: Prolonged exposure to glucocorticoid suppresses the function of human BAT. The enhancement of energy production and lipogenesis in the face of reduced dissipation of energy as heat suggests that glucocorticoids channel energy towards fat storage after nutrient intake. This is a novel mechanism of glucocorticoid-induced obesity.
How to read the result without overreaching
During cooling, supraclavicular temperature change was −1.0±0.1°C with prednisolone versus −0.45±0.1°C with placebo (P<0.01); BAT FDG uptake also fell. This finding belongs to the cited design, population and timepoint. It should not be converted into a diagnosis, a universal rule, or proof that a cosmetic moisturizer prevents or treats disease.
Small drug-mechanism study; it is not a skincare trial and must not guide corticosteroid use without a prescriber. The result may still help readers notice which parts of daily life deserve attention: exposure duration, recovery time, anatomical site, product or material formulation, and whether the comparison was randomized, observational or within-person.
Questions the paper can—and cannot—answer
The paper can describe the measurements made under its stated conditions and the uncertainty visible in its design. It cannot establish that every adult will respond the same way, that a different fabric or formula will behave identically, or that a short instrumental change equals a meaningful health outcome. Numerical readings also depend on calibration, room conditions, acclimation, body site and timing.
For practical decisions, the most defensible takeaway is to separate exposure management from cosmetic care. Adjusting friction, heat, moisture, glove or clothing practices may be relevant to the activity itself. A moisturizer has a narrower role: supporting hydration, the moisture barrier and dry-skin comfort. Persistent or worsening symptoms require individualized clinical evaluation rather than extrapolation from this study.
Practical, claim-safe routine thinking
- Use the gentlest routine that fits the task and workplace rules.
- After washing, dry carefully and pay attention to repeated friction, heat and occlusion.
- For persistent cracking, rash, swelling, pain, drainage or infection concerns, seek qualified medical care.
- Do not assume that results from a study formulation, device, sock, cleanser, glove or shower system apply to a different product.
Where Dr. Arsy #003 fits—and where it does not
Dr. Arsy #003 is a cosmetic face-and-body moisturizer for hydration, moisture-barrier support and dry-skin comfort. It was not tested in the cited study, and the study’s outcomes are not being transferred to #003. This article does not claim treatment, cure, prevention, itch or pain relief, universal tolerance, pediatric safety, or 24-hour protection.
View Dr. Arsy #003 Moisturizer
Continue reading
- Air-Filled Vest Under Ballistic Protection in 16 Men
- Concealed Body-Armor Microclimate at 26°C and 30°C
- Three-Hour Sitting With Walking Breaks in 12 Men
- Cooling Vest After Hyperthermia in 10 Men
Primary and authoritative sources
- Primary PubMed record: Prednisolone and Cooling Responses in 13 Adults
- CDC/NIOSH: skin exposures and effects
- American Academy of Dermatology: dry-skin care
PubMed indexing identifies a bibliographic record; it is not NIH endorsement.